Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Neurosci ; 22(12): 5188-97, 2002 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-12077213

RESUMO

Using homologous recombination, we generated mice lacking phosphodiesterase-mediated (PDE1B) cyclic nucleotide-hydrolyzing activity. PDE1B(-/-) mice showed exaggerated hyperactivity after acute D-methamphetamine administration. Striatal slices from PDE1B(-/-) mice exhibited increased levels of phospho-Thr34 DARPP-32 and phospho-Ser845 GluR1 after dopamine D1 receptor agonist or forskolin stimulation. PDE1B(-/-) and PDE1B(+/-) mice demonstrated Morris maze spatial-learning deficits. These results indicate that enhancement of cyclic nucleotide signaling by inactivation of PDE1B-mediated cyclic nucleotide hydrolysis plays a significant role in dopaminergic function through the DARPP-32 and related transduction pathways.


Assuntos
Atividade Motora , Proteínas do Tecido Nervoso , Fosfoproteínas/metabolismo , Diester Fosfórico Hidrolases/genética , Diester Fosfórico Hidrolases/fisiologia , Receptores de Dopamina D1/agonistas , Animais , Comportamento Animal , Encéfalo/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Nucleotídeo Cíclico Fosfodiesterase do Tipo 1 , Fosfoproteína 32 Regulada por cAMP e Dopamina , Feminino , Marcação de Genes , Cinética , Masculino , Aprendizagem em Labirinto , Memória , Camundongos , Camundongos Knockout , Fosforilação , RNA Mensageiro/biossíntese
2.
Neurotoxicol Teratol ; 27(1): 117-34, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15681126

RESUMO

We have previously shown that P11-20 treatment with d-methamphetamine (MA) induces impaired spatial navigation in the Morris water maze (MWM), whereas P1-10 treatment does not. Little is known about the long-term behavioral consequences of MA during juvenile, adolescent, and early adult brain development. In dose-response experiments, we tested successive 10-day intervals of exposure to MA in rats (P21-30, P31-40, P41-50, and P51-60; four doses per day). MA dosing prior to P21 produces little or no toxicity; however, we observed an increased toxicity with advancing age. Across-age comparisons revealed no MWM acquisition or Cincinnati water maze (CWM) effects after MA treatment on P21-30 (2.5-10 mg/kg/dose), P31-40 (1.25-7.5 mg/kg/dose), or P51-60 (1.25-5.0 mg/kg/dose); however, significantly impaired MWM acquisition was observed after P41-50 MA treatment at the highest dose (6.25 mg/kg/dose). Learning in the CWM was also impaired in this group. No effects were seen at 1.25, 2.5, or 5 mg/kg/dose following P41-50 MA treatment. MWM reversal learning trials after P41-50 treatment showed a trend towards longer latency in all MA dose groups, but no effect on double-reversal trials. Reversal and double-reversal also showed no effects at the other exposure ages. No differences in straight channel swimming or cued learning in the MWM were seen after MA treatment at any exposure age. P41-50 is the periadolescent stage of brain development in rodents. The effects observed at this age may suggest a previously unrecognized period of susceptibility for MA-induced cognitive deficits.


Assuntos
Envelhecimento/fisiologia , Estimulantes do Sistema Nervoso Central/toxicidade , Dextroanfetamina/toxicidade , Deficiências da Aprendizagem/induzido quimicamente , Deficiências da Aprendizagem/fisiopatologia , Comportamento Espacial/efeitos dos fármacos , Fatores Etários , Envelhecimento/efeitos dos fármacos , Análise de Variância , Animais , Animais Recém-Nascidos , Comportamento Animal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Suscetibilidade a Doenças/induzido quimicamente , Suscetibilidade a Doenças/fisiopatologia , Relação Dose-Resposta a Droga , Esquema de Medicação , Reação de Fuga/efeitos dos fármacos , Feminino , Deficiências da Aprendizagem/mortalidade , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Mortalidade , Gravidez , Ratos , Ratos Sprague-Dawley , Fatores Sexuais , Natação
3.
Int J Dev Neurosci ; 22(5-6): 247-59, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15380825

RESUMO

3,4-methylenedioxymethamphetamine (MDMA) in previous experiments has been shown to induce long-term spatial and sequential learning and memory deficits in adult offspring after exposure to the drug on postnatal (P) days 11-20, but not after exposure on P1-10. Herein we further tested for the effects of MDMA (0, 5, 10 or 20 mg/kg x 2/day) after exposure on P11-20 on reference and working memory in the Morris water maze (MWM), on reference memory in the Barnes maze, and on cued learning in the visible platform version of the MWM. The MWM and Barnes mazes were counterbalanced such that half the litters received the MWM-first and the other half received the Barnes maze first. Effects on MWM performance as a function of test order were observed. For animals that received the Barnes maze first, spatial MWM learning and memory trends were seen but they were not significantly different between MDMA groups and saline controls. For those receiving the MWM-first, there are consistent impairments on all measures in the MDMA groups compared to controls on MWM performance (latency, path length, and cumulative distance from the goal). On probe trials, MDMA animals receiving the MWM-first showed increased distance from the target site compared to controls. There were no MDMA effects seen on cued trials in the MWM or on straight channel swimming trials regardless of test order, indicating that MDMA had no effects on swimming ability or on the skills needed to learn the MWM. Similarly, there were no effects of MDMA on MWM working memory regardless of test order. No MDMA effects on the Barnes maze were found regardless of test order, however, the interpretation of this finding was compromised by the poor performance of the animals on this task.


Assuntos
Aprendizagem em Labirinto/efeitos dos fármacos , Aprendizagem em Labirinto/fisiologia , Memória/efeitos dos fármacos , Memória/fisiologia , N-Metil-3,4-Metilenodioxianfetamina/administração & dosagem , Desempenho Psicomotor/efeitos dos fármacos , Desempenho Psicomotor/fisiologia , Fatores Etários , Envelhecimento/efeitos dos fármacos , Envelhecimento/fisiologia , Animais , Animais Recém-Nascidos , Relação Dose-Resposta a Droga , Feminino , Alucinógenos/administração & dosagem , Masculino , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA